drugset / Trial / NCT05099276

Extended Postoperative Oral Tranexamic Acid in Knee Replacement

NCT05099276 ↗

Phase 4 Unknown 46 enrolled Campbell Clinic
RandomizedParallel-groupSingle-blindOther

Summary

A comparison of outcomes between use of oral tranexamic acid as compared to oral placebo in the first days after total knee replacement will be made to determine impact on clinical indications and patient reported outcomes.

Timeline

Start
2021-12-07
Primary completion
2023-12-31
Completion
2024-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1950 mg Oral

Indications